Emerging Therapeutic Company Investment, By the Numbers

2:00 PM - 2:45 PM (EDT), Monday, June 14, 2021
Search General Info
Search Education
Search Partnering Companies
David Thomas, BIO’s Vice President of Industry Analysis, will provide an overview of new investment and deal trends for emerging therapeutic companies. Join this must-attend session for the latest data on licensing, M&A, venture capital, IPOs, follow-on public offerings, the therapeutic pipeline, FDA approvals, and drug development success rates.
Speaker
photo
Vice President, Industry Research
Biotechnology Innovation Organization